Medical Device Registration in China
|
|
- Tiffany Tate
- 6 years ago
- Views:
Transcription
1 IVD Medical Device Registration in China
2 Your Local Regulatory Affairs Staff-CIRS CIRS assist you Overseas Medical Devices In Vitro Diagnostic reagent Market access CFDA Registration Pre-market Approval Post-market surveillance China Market I. Regulatory Strategy for Medical Device Market Access in China Healthcare Product Is your product a medical device or in vitro diagnostic (IVD) reagent in China? Have you already applied for and obtained the appropriate license or registration certificate? Subject to other regulations? (e.g. regulations on drug, cosmetic, disinfectant, etc.) Apply for license or registration certificate update or renewal Pre-market Approval: Classification, testing, clinical trial, submission and evaluation, labeling, license for manufacturing and distributing, Customs clearance, etc. Post-market Surveillance: Quality assurance (GMP or GSP), advertisement approval, adverse event monitoring and reporting, recall, etc.
3 II. Classification of A Medical Device Medical device classification lays the foundation of the registration requirements and procedures. All class III and imported devices are managed directly by the central CFDA. Medical devices are classified in 3 classes, namely Class I, II and III medical devices. The classification system is based on the risk via integrated evaluating of intended purpose, structure features, use methods and other factors of medical device: Class I Medical devices are those with low risk degree and for which safety and effectiveness can be ensured through routine administration; Class II Medical devices are those with moderate risk and for which strict administration is required to ensure their safety and effectiveness Class III Medical devices are those with higher risk and which must be strictly controlled via special measures in respect to safety and effectiveness. III. Registration Requirements and Types for Imported Medical Devices Registration types Testing Clinical Trial Authorities Deadline Class I Record Self-testing N/A CFDA Pre-market Class II Class III Initial Registration Required Required CFDA Pre-market Updates TBA TBA CFDA Renewal TBA N/A CFDA Initial Registration Within 1months after being updated 6 months before the date of certificate expired Required Required CFDA Pre-market Updates TBA TBA CFDA Renewal TBA N/A CFDA Within 1months after being updated 6 months before the date of certificate expired
4 IV. Registration and Approval Process Classification Determined and Documents Gathered If required Appoint the Chinese Legal Representative and Service Agent Registration Strategy (Panning & Proposal) Class I Medical Devices Dossier preparation and submitted Define the Product Technical Requirements ( Former Standard ) Class II & III Medical Devices Deliver samples and Testing, Dossier preparation and submitted If required Dossier formal review and correction Clinical Trial, CSR finalized Correction Qualified Technical evaluation in Center for Administrative Service and CMDE Qualified Supplementatio n Administrative Approval and Record-keeping Issued Administrative Approval and Registration Certificate Issued Post-market Surveillance: Quality assurance (GMP or GSP), advertisement approval, adverse event monitoring and reporting, recall, etc. (more info. Can be found here:
5 V. Clinical Trail Requirements Is it Medical Devices Is it class I medical devices in China? Is it listed in the catalog of medical devices exempted from clinical trial Submission of clinical evaluation report (exemption) Does it comply with the national or industrial standard? Conduct the clinical study according to the provisions for clinical trials of medical devices in China (GCP) VI. What Can We Do for You? Aims to favor more and more abroad outstanding medical devices and technologies entering China market, CIRS leads extensive resource and establishes the full life-cycle service for your product. We start from helping you with the pre-market investigation, and there is no ending of our service:
6 Pre-market Investigation & Analysis Medical Devices Registration & Approval Clinical Trial Consulting Manufacturing and Distributing License Approval Quality Assurance & Compliance Risk Assessment & Management Customs Clearance IPR Protection in China China Medical Device Regulatory Database (CMDRD) Recall & Reevaluatio n Supervisi on & Administr ation Develop ment & Design CIRS works with you to design and implement the risk management system for the entire lifecycle of your medical device in China Registrati on & Approval Manufact ure and QMS Use Distributi on & Transmis sion Why CIRS? Qualified and experienced regulatory affairs team Full understanding of the medical device regulations Close ties with local authorities and related research institutions Full life-cycle risk management service for medical device A completely neutral third party focusing only on regulatory services Strictly respect and protect client's and proprietary interests Contact us Hangzhou CIRS Co., Ltd ADD: 11F Building 1, Dongguan Hi-Tech Park, 288 Qiuyi Road, Binjiang District, Hangzhou , China Tel: Fax: MD@cirs-group.com http: //
Technical Guiding Principle on Medical Devices Clinical Evaluation Article 1 Objective
Technical Guiding Principle on Medical Devices Clinical Evaluation Article 1 Objective Medical devices clinical evaluation is the procedure for registration applicant to confirm whether the product can
More informationContents. Regulatory Bodies... 13
Contents UNITED STATES... 3 Regulatory Bodies... 3 Product Classification and Regulatory Control... 3 Application Documents... 3 Quality System Requirements... 4 Product and Manufacturer s License... 4
More informationSPECIAL APPROVAL PROCEDURES FOR INNOVATIVE MEDICAL DEVICES IN CHINA
SPECIAL APPROVAL PROCEDURES FOR INNOVATIVE MEDICAL DEVICES IN CHINA What is the Innovative device pathway? Based on CFDA Order [2014] No. 13 In February 2014, the China Food and Drug Administration released
More informationIn the huge expanse of Asia, Singapore and
New Medical Device Regulation 16 February 2009 By Ames Gross In the huge expanse of Asia, Singapore and Hong Kong are small places. However, after Japan, they are among the most advanced medical markets
More informationHow to access the Chinese Medical Device Market
In Partnership With How to access the Chinese Medical Device Market The China Britain Business Council (CBBC) Tuesday 12 th May 2015 A project funded by the European Union Get Ready for China! The EU SME
More informationRegulatory Requirements for Medical Devices in China
Regulatory Requirements for Medical Devices in China Syneos Health TM 2018 Syneos Health. All rights reserved. How to Register a Foreign Medical Device in China Classification Class 1 Class 2 Class 3 Authority
More informationRegulatory requirements and registration process of Generic Drugs in China
13 Regulatory requirements and registration process of Generic Drugs in China Jitendra Kumar Badjatya Deputy Manager-DRA, Montajat Pharmaceutical Company Limited, Dammam, KSA jeetbadjatya@gmail.com ABSTRACT
More informationOMBU. Ombu Enterprises, LLC Ombu The Operational Excellence Company Ph: Fax: ENTERPRISES, LLC
OMBU ENTERPRISES, LLC Ombu Enterprises, LLC Ombu The Operational Excellence Company Ph: 603-209-0600 Fax: 603-358-3083 OmbuEnterprises@msn.com Docket Number FDA-2010-N-0274 Comments on Oversight of Laboratory
More informationTuesday, 21 October Jang Yong Choi
Tuesday, 21 October 2014 Jang Yong Choi Contents Status of Medical Device Industry in Korea MFDS Organization and Responsibilities Medical Device Regulation Overview Medical Device Regulation Updates I.
More informationKorean Medical Devices Regulations
Korean Devices Regulations The Ministry of Health and Welfare (MHW) is the healthcare agency having overall responsibility for Devices. The Korea Food and Drug Administration (MFDS), an agency under MHW,
More informationDi Renzo Regulatory Affairs ROME - MILAN - LONDON
Di Renzo Regulatory Affairs ROME - MILAN - LONDON Di Renzo Regulatory Affairs In 1985, Di Renzo Regulatory Affairs began its regulatory consulting for medicines for human and veterinary use, food and dietary
More informationCourse Title ID Duration Basic Premium. Biological Evaluation of Medical Devices: A Risk-Based Approach N mins
Pre-Clinical Basic Level : CMDA Certified Medical Device Associate Biological Evaluation of Medical Devices: A Risk-Based Approach N134 63 mins 186.00 144.00 Introduction to Process Validation N135 75
More informationMEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL GUIDELINE FOR A LICENCE TO MANUFACTURE, IMPORT, EXPORT OR DISTRIBUTE MEDICAL DEVICES & IVDs This guideline is intended to provide recommendations to applicants wishing to submit
More informationMedical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS
Medical Device Regulatory Framework 9 SEPTEMBER 2015 FUNDISA CONFERENCE JANE ROGERS Key Topics Definitions Essential Principles Classification Conformity Assessment Framework License to Manufacture, Import,
More informationTechnical Guidance on Clinical Evaluation of Medical Devices
Annex Technical Guidance on Clinical Evaluation of Medical Devices I. Purpose The clinical evaluation of medical devices is the assessment procedure conducted by registration applicants to validate whether
More informationGuideline on New Food Raw Materials Chinese Market Access
Guideline on New Food Raw Materials Chinese Market Access Tel: +86 571-87206538 Fax: +86 571-87206533 Email: food@cirs-group.com www.cirs-reach.com Foreword With the rapid development of food industry
More informationDisclosures. Laboratory Stakeholders. IVD vs. LDT. FDA Regulation of Laboratory Developed Tests 10/2/2015. FDA Regulation of LDTs
Disclosures FDA Regulation of Laboratory Developed Tests Beaumont Health System, 24 th Annual Symposium on Molecular Pathology September 16, 2015 Roger D. Klein, MD JD Director, Molecular Pathology Clinical
More informationGMP. Safeguard The Patient s Health.
GMP Safeguard The Patient s Health. Scope. Products and testing according to pharma industry standard. Good Manufacturing Practice or GMP are practices and systems that are required to be adapted in pharmaceutical
More informationDrug Regulation. Overview of Regulatory Trends in Biological Products. Jan 2018 Washington
Drug Regulation Overview of Regulatory Trends in Biological Products Jan 2018 Washington 1 Table of Contents Main Features of biological products Supervision of biological products Progress of regulatory
More informationCHINA S HEALTHCARE INDUSTRY. Israel at a glance
CHINA S HEALTHCARE INDUSTRY CHINA S HEALTHCARE INDUSTRY CHINA S MEDICAL DEVICES SECTOR 600 Sale Revenue Medical Device from 2001 to 2016 in China (Unit: 100 Million US Dollars) 567 15,698 registered manufacturers
More informationInterpretation of The Catalog of Hazardous Chemicals (2015)
Interpretation of The Catalog of Hazardous Chemicals (2015) Enabling Chemical Compliance for A Safer World Christine Chuang, Senior Regulatory Affairs Consultant, CIRS China 26 March 2015 Email: Christine.chuang@cirs-group.com
More informationTips to Taiwan Medical Device Regulation
Tips to Taiwan Medical Device Regulation 15 th March, 2017 Rachel Tserng Qualification in Biotechnology and Business Bilingual in English and Mandarin Experience in preparation and management of regulatory
More informationData Requirements for New Chemical Notification in China Please go to for more info about China REACH
Data Requirements for New Chemical Notification in China Please go to http://www.cirs-reach.com/ for more info about China REACH Original Article by Chemical Inspection and Regulation Service (CIRS) in
More informationMed-Info. Introduction to Korean medical device regulations. TÜV SÜD Product Service GmbH
Med-Info International expert information for the medical device industry Introduction to Korean medical device regulations The Ministry of Food and Drug Safety () is the healthcare agency having overall
More informationTHE NEW FOOD AND DRUG ADMINISTRATION (FDA) OF THE REPUBLIC OF THE PHILIPPINES
THE NEW FOOD AND DRUG ADMINISTRATION (FDA) OF THE REPUBLIC OF THE PHILIPPINES Agnette de Perio Peralta and Maria Cecilia Credo Matienzo (apperalta@co.doh.gov.ph and mccmatienzo@yahoo.com) Center for Device
More informationYour Vision, Our Future Korean Medical Device Your Vision, Our Future
www.mfds.go.kr/eng Your Vision, Our Future Korean Korean Your Vision, Our Future 01 Passion for Growth & Excellence With a 5% average annual growth rate, the Korean medical device market was valued at
More informationPaths to Market & FDA Product Lifecycle Regulation. Patricia Kaeding Design of Medical Devices University of Minnesota April 14, 2005
Paths to Market & FDA Product Lifecycle Regulation Patricia Kaeding Design of Medical Devices University of Minnesota April 14, 2005 FDA Organization U.S. Food & Drug Administration Headed by a Commissioner
More informationMed-Info. Introduction to Korean medical device regulations. TÜV SÜD Product Service GmbH
Med-Info International expert information for the medical device industry Introduction to Korean medical device regulations The Ministry of Food and Drug Safety (MFDS) is the healthcare agency having overall
More informationREGISTRATION OF MEDICAL DEVICE. SUBMISSION & APPLICATION By IDAMAZURA IDRIS MEDICAL DEVICE AUTHORITY
REGISTRATION OF MEDICAL DEVICE SUBMISSION & APPLICATION By IDAMAZURA IDRIS MEDICAL DEVICE AUTHORITY Medical device: regulated item under the Medical Device Act 2012 (Act 737) and its regulation The objective:
More informationThe interface between Good Clinical Practice and Good Manufacturing Practice
1 The interface between Good Clinical Practice and Good Manufacturing Practice your partner in compliance 1 The interface between GCP and GMP Generally, studies are designed and planned by physicians who
More informationTechnical Guidance on Clinical Evaluation of Medical Devices 1
Technical Guidance on Clinical Evaluation of Medical Devices 1 I. Purpose The clinical evaluation of medical devices is the assessment procedure conducted by registration applicants to validate whether
More informationStaffing - Medical Devices
Staffing - Medical Devices LONDON GENEVA SINGAPORE DUBLIN procorre.com 1 Implementing solutions to clients worldwide 2 Contents Services 04 Sector Overview 07 Medical Devices 07 In-Vitro Diagnostics 08
More informationKorea Medical Device Regulatory Requirements Update
Korea Medical Device Regulatory Requirements Update April 28 th, 2015 Prepared by MinYong Choi UL Korea, Ltd. UL and the UL logo are trademarks of UL LLC 2015 MinYong Choi Engineering Leader Medical Regulatory
More informationJob Openings at SoliPharma
Openings at SoliPharma Posted on Feb 22, 2018 Corporate Overview SoliPharma is a specialty pharmaceutical company established in 2010, with major operation in Hangzhou China and Boston USA. We have full-range
More informationHOW TO APPLY FOR MEDICAL DEVICE REGISTRATION UNDER MEDICAL DEVICE ACT 2012 (ACT 737)
MDA/GL No 1: July 2013 Guidelines for implementation of medical device regulatory system HOW TO APPLY FOR MEDICAL DEVICE REGISTRATION UNDER MEDICAL DEVICE ACT 2012 (ACT 737) [Appendix 4 Schedule 3 Medical
More informationMedical Device Single Audit Program (MDSAP) An Overview Canadian Experience
Medical Device Single Audit Program (MDSAP) An Overview Canadian Experience Linda Chatwin Sr. Customer Solutions Consultant : 360-817-5556 : linda.chatwin@ul.com LINDA M CHATWIN, Esq, RAC Biography Ms.
More informationDrug Registration in BRICS countries: Opportunities and Challenges. Judith ter Horst 1 November 2018
Drug Registration in BRICS countries: Opportunities and Challenges Judith ter Horst 1 November 2018 Once a drug reaches Phase1, it s a good idea to start discussions with global regulatory authorities
More informationTechnical Guidelines for Clinical Evaluation on Medical Devices
Appendix Technical Guidelines for Clinical Evaluation on Medical Devices I. Preparation Objective The clinical evaluation of medical devices refers to the process for conforming whether the products meet
More informationThe Long and Winding Road of Unique Device Identifier (UDI) Implementation: A Small Company Perspective
The Long and Winding Road of Unique Device Identifier (UDI) Implementation: A Small Company Perspective Daniel Simpson, RAC (US,CAN), ASQ CBA Sr. Director of Quality and Regulatory Affairs Corgenix, Inc
More informationEXPERT ISE YOU CAN TRUST
EXPERT ISE YOU CAN TRUST 03 Contents INTRODUCTION 04 THIS IS WHO WE ARE 06 THIS IS WHAT WE DO 08 OUR SERVICES 10 Regulatory Strategy Services 12 Product Registrations & Maintenance 13 Electronic Publishing
More informationCTA/NDA Regulatory Landscape in China. Jack Xie, PhD, DABT SOT 2016
CTA/NDA Regulatory Landscape in China Jack Xie, PhD, DABT SOT 2016 Disclaimer The content of the following presentation represents solely author s view and may not reflect any position of Roche or China
More informationData Collection Tools Functions, Indicators & Sub-Indicators
Data Collection Tools 27- Functions, Indicators & A. National regulatory system Indicator RS1: Legal framework for establishment of a regulatory system, mandate and enforcement power for each function
More informationChallenges for further effectiveness
ANVISA and INMETRO Challenges for further effectiveness www.nihonkohden.com Nihon Kohden do Brasil Kotaro Ichikawa Great Improvements Class I & II: From 6 8 to 2 3 months Class III & IV: From 12 18 to
More informationINDO AFRICA PHARMA MEET 24-27TH SEPT, Hotel Marriot Hussain Sagar Lane, Road, Hyderabad India SPONSORED BY PHARMEXCIL
INDO AFRICA PHARMA MEET 24-27TH SEPT, 2009 Hotel Marriot Hussain Sagar Lane, Road, Hyderabad India SPONSORED BY PHARMEXCIL Drug Registration procedures in Tanzania Nditonda B. Chukilizo and Adonis Bitegeko
More informationImpact of the IVD Regulations. Barbara Fallowfield Managing Director
Impact of the IVD Regulations Barbara Fallowfield Managing Director What will I cover today? Timelines Key Changes Classification Clinical Evidence Requirements Third Parties Vigilance and Post Marketing
More informationIndia Authorized Agent Representative for medical device Companies. Responsibilities of the India Authorized Agent representative.
India Authorized Agent Representative for medical device Companies Entellus Food & Drugs Regulatory Services Pvt. Ltd. representing medical device companies with no registered location in India must appoint
More informationInitial registration of import products
Initial registration of import products A. The Direction for the Application Form of Registration 1. All the contents filled in shall be in both Chinese and English; 2. Upon the application, the form shall
More informationThe Medical Device Coordination Group: a new Authority Under EU Device Regulations
The Medical Device Coordination Group: a new Authority Under EU Device Regulations By Robert D. Cumming and Nancy W. Mathewson, Esq. This article discusses the organization and functions of the Medical
More informationChina In-Vitro Diagnostics (IVD) Market, Company Analysis & Forecast to 2022
China In-Vitro Diagnostics (IVD) Market, Company Analysis & Forecast to 2022 China In-Vitro Diagnostics (IVD) Market, Company Analysis & Forecast to 2022 BioPortfolio has been marketing business and market
More informationVDI 3400 Texture Material:
Medical injection molding for diagnostic equipment. It is used for clinical diagnosis in hospital. It is made for our Singapore customer. low volume production for second type medial device with high requirements.
More informationGuide to Scientific and Regulatory Advice for GXP activities
Guide to Scientific and Regulatory Advice for GXP activities ADV-G0019-1 7 OCTOBER 2017 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only.
More informationQUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION
PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PS/W 1/2011 2 Annexes 22 July 2011 QUESTIONNAIRE FOR COMPETENT AUTHORITIES TO BE USED FOR ASSESSMENT, REASSESSMENT AND SELF- EVALUATION PIC/S 2011 Reproduction
More informationCOUNTRY OVERVIEW: THAILAND. August 2012 SPECIAL REPRINT. By Rarana Phanudulkitti
August 2012 SPECIAL REPRINT COUNTRY OVERVIEW: THAILAND By Rarana Phanudulkitti Reproduced with the kind permission of Global Regulatory Press from the Journal of Medical Device Regulation, 2012, 9(3),
More informationMEDICAL DEVICES SECTOR BUSINESS PROCESS MANAGEMENT MATURITY (BPMM) ASSESSMENT. Friday, November 15, 2013
MEDICAL DEVICES SECTOR BUSINESS PROCESS MANAGEMENT MATURITY (BPMM) ASSESSMENT Presented at Business Building Capability conference Las Vegas, NV Nov 11-15, 2013, Ph.D Vice Executive President -Medical
More informationPROPOSED DOCUMENT. Global Harmonization Task Force. Title: Principles of Conformity Assessment for In Vitro Diagnostic (IVD) Medical Devices
SG1(PD)/N046R3 PROPOSED DOCUMENT Global Harmonization Task Force Title: Principles of Conformity Assessment for In Vitro Diagnostic (IVD) Medical Devices Authoring Group: Study Group 1 of the Global Harmonization
More informationMDS-G25. Guidance on Requirements for Storage, Handling and Transportation of Medical Devices
MDS-G25 Guidance on Requirements for Storage, Handling and Transportation of Medical Devices Version Number: 1.0 Version Date: 10/4/2018 This guidance document has been published after being distributed
More informationUnderstanding CFDA Expectations Regarding Clinical Literature Evaluation for Medical Devices under Order 650: A Nerac Perspective
Understanding CFDA Expectations Regarding Clinical Literature Evaluation for Medical Devices under Order 650: A Nerac Perspective Part I: The Predicate Device Problem By Richard Conforti, M.S., Nerac Analyst
More informationKorea's Medical Device Regulatory Structure - Introduction
Korea's Medical Device Regulatory Structure - Introduction South Korea first introduced the Medical Device Act in 2003 to protect the public from unsafe devices and serve the interests of many different
More informationMarketing authorization of medical devices in China
Marketing authorization of medical devices in China Article (Accepted Version) Zhang, Weifan, Lui, Rebecca and Chatwin, Chris (2016) Marketing authorization of medical devices in China. Journal of Commercial
More informationRegulatory Overview of Proposed LDT Framework. FDA Concerns. Background. FDA Proposed Regulatory Approach. By Ben Berg, Meaghan Bailey, RAC
Regulatory Overview of Proposed LDT Framework By Ben Berg, Meaghan Bailey, RAC On July 31, 2014, the U.S. Food and Drug Administration (FDA or the Agency) notified both the Senate Committee on Health,
More informationUpdate on China-Denmark Food and Drug Regulatory Cooperation Centre
Update on China-Denmark Food and Drug Regulatory Cooperation Centre Stakeholder meeting, 7 December 2017 Jakob Cold, Deputy Director General State of Play China-Denmark Drug Administrative Law Exchange
More informationDRUG DRAFT GUIDELINE FOR REGISTRATION OF MEDICAL DEVICES FOR HUMAN USE IN UGANDA, SEPTEMBER 2009
DRUG NATIONAL AUTHORITY DRAFT GUIDELINE FOR REGISTRATION OF MEDICAL DEVICES FOR HUMAN USE IN UGANDA, SEPTEMBER 2009 TABLE OF CONTENTS: 1 INTRODUCTION 2 DEFINITION OF MEDICAL DEVICE 3 SCOPE OF THE GUIDELINE
More informationJob Title: Head, Clinical Science Job Location: Nanjing, China CV to: Wechat:
Job Title: Head, Clinical Science Job Description: As a senior member of the Clinical Development organization, the Head of Clinical Science will supervise a team of staff to lead the clinical development
More informationTitle: Department: Approved by: Director, Human Research Review and Compliance
Title: Department: Requirements for Investigational New Drug (IND) for Human- Subjects Research Human Research Affairs Policy Type: Partners System-wide Partners System-wide Template Partners HealthCare
More informationOverview of Regulatory Framework for Medical Devices & IVDs and likely Implementation Roadmap. Jane Rogers SAAPI Conference 13 April 2016
Overview of Regulatory Framework for Medical Devices & IVDs and likely Implementation Roadmap Jane Rogers SAAPI Conference 13 April 2016 Regulatory Framework for Medical Devices & IVDs HAZARDOUS SUBSTANCES
More informationFINAL DOCUMENT. Global Harmonization Task Force. Title: Principles of Conformity Assessment for In Vitro Diagnostic (IVD) Medical Devices
GHTF/SG1/N046:2008 FINAL DOCUMENT Global Harmonization Task Force Title: Principles of Assessment for In Vitro Diagnostic (IVD) Medical Devices Authoring Group: Study Group 1 of the Global Harmonization
More informationDrug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel
Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel On February 13th, 2006, the FOOD AND DRUG ADMINISTRATION (FDA) implemented a revision to the Compliance Program Guidance Manual for active
More informationPharmaceutical Trademarks
Published by Pharmaceutical Trademarks 2012 Hungary Contributing firm Third Edition Hungary Contributing firm Author Georgina Busku Selection, clearance and registration The following trademarks may enjoy
More informationKFDA Regulatory Framework on Biopharmaceuticals - Focus on Biosimilar
KFDA Regulatory Framework on Biopharmaceuticals - Focus on Biosimilar Kyung-Min Baek, Ph.D. Recombinant Protein Products Division Korea Food and Drug Administration(KFDA) Biopharmaceuticals A biopharmaceutical
More informationPrequalification of in vitro diagnostics - Technical Update 24 November 2015
Prequalification of in vitro diagnostics - Technical Update 24 November 2015 Copenhagen, Denmark 22-26 November 2015 1 Changes assessment Copenhagen, Denmark 22-26 November 2015 2 Changes to a Prequalified
More informationOffice for Human Subject Protection. University of Rochester
POLICY 1. Purpose Outline the responsibilities and regulatory requirements when conducting human subject research that involves the use of drugs, agents, biological products, or nutritional products (e.g.,
More informationHandling of Marketing Application for Combination Products
October 24, 2014 To: Commissioner of Prefectural Health Department (Bureau) N o t i f i c a t i o n PFSB/ELD Notification No. 1024-2 PFSB/ELD/OMDE Notification No. 1024-1 PFSB/SD Notification No. 1024-9
More informationMedical Device Regulatory Roadmap SAMED Conference 2-3 December 2015
Medical Device Regulatory Roadmap SAMED Conference 2-3 December 2015 Dr J. Gouws Registrar of Medicines Status in RSA: 2 December 2015 Legislation: Bill 6D, 2014 Defines MD and IVDs Licensing of Manufacturers,
More informationThe China In Vitro Diagnostics (IVD) Market has been analyzed from 4 View Points:
China In Vitro Diagnostics (IVD) Market - Overview China In-Vitro Diagnostics (IVD) market is among the fastest growing in the world. It is anticipated that China IVD market will more than triple by 2020
More informationUnderstanding GxP Regulations for Healthcare
Understanding GxP Regulations for Healthcare GxP Guidelines What is GxP? GxP is a collection of quality guidelines and regulations created to ensure that bio/pharmaceutical products are safe, meet their
More informationINFORMATION REQUIRED FROM PHARMACEUTICAL FIRMS FOR REGISRATION
INFORMATION REQUIRED FROM PHARMACEUTICAL FIRMS FOR REGISRATION Part A: Details of the market Authorization holder (local agent)- 1. Name of Company: 2. Address and contact details of the company : 3. a)
More informationRegulatory Perspectives of Japan
International Alliance for Biological Standardization (IABS) Challenge Toward Sound Scientific Regulation of Cell Therapy Products at Kyoto International Conference Center, Kyoto, Japan Regulatory Perspectives
More informationTransport Planning Technician Apprenticeship
Assessment Plan Summary Transport Planning Technicians provide technical support to professional transport planners in the preparation, assessment and implementation of policies, plans and projects to
More informationIVDR Update Get Ready for the Ride. MassMEDIC World MedTech Regulatory Update
IVDR Update Get Ready for the Ride MassMEDIC World MedTech Regulatory Update Carol C. Ryerson, Ph.D. Sr. Principal Advisor, Regulatory Affairs Jun 8, 2017 Agenda Overview of the IVDR (EU) 2017/746 Business
More informationMEDICAL DEVICE GUIDANCE DOCUMENT REQUIREMENTS FOR LABELLING OF MEDICAL DEVICES
November 2018 Third Edition MEDICAL DEVICE GUIDANCE DOCUMENT REQUIREMENTS FOR LABELLING OF MEDICAL DEVICES Medical Device Authority MINISTRY OF HEALTH MALAYSIA Contents Page Preface.... iii 1 Introduction....
More informationMedical Device Regulatory Roadmap SAMED Conference 2-3 December 2015
Medical Device Regulatory Roadmap SAMED Conference 2-3 December 2015 Dr J. Gouws Registrar of Medicines Overview Global status on MD and IVDs National status on MD and IVDs Legislation Key player and Responsibilities
More informationGxP Auditing, Remediation, and Quality System Resourcing
GxP Auditing, Remediation, and Quality System Resourcing TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 6 GLP Auditing 7 Pharmacovigilance Auditing 7 Vendor/Supplier Auditing
More informationGood Distribution Practices Toolkit Change Control 10 March 2016
Good Distribution Practices Toolkit Change Control 10 March 2016 1 Disclaimer The content of this presentation were derived mainly from WHO training material on Change Control and edited to suit the Distributor
More informationContents. 1. Administrative Organizations and Affairs under Jurisdiction for Veterinary Medical Devices
Assurance System of Quality, Performance, and Safety of Veterinary Medical Devices Based on the Law for Ensuring the Quality, Efficacy, and Safety of Drugs and Medical Devices Animal Products Safety Division
More informationSession 4: Ensuring Product Quality Throughout the Supply Chain
Session 4: Ensuring Product Quality Throughout the Supply Chain Potential Quality Assurance Checkpoints Within the Overall Supply Chain 1. Raw Materials / Components 2. Manufacturing 3. Packaging 6. Receiving
More informationMedical Devices. LATVIA LAWIN Klavins & Slaidins
Medical Devices LATVIA LAWIN Klavins & Slaidins CONTACT INFORMATION Sarmis Spilbergs LAWIN Klavins & Slaidins Elizabetes 15, Riga, LV 1010, Latvia +371 67814848 sarmis.spilbergs@lawin.lv www.lawin.com
More informationGuidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff
Guidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff Guidance on Informed Consent for In Vitro Diagnostic Device Studies Using Leftover Human Specimens that are Not
More informationRegulatory Framework in Japan - Past and Future - Building a Regulatory Framework Essential Elements of Compliance / Surveillance
Regulatory Framework in Japan - Past and Future - Building a Regulatory Framework Essential Elements of Compliance / Surveillance Nobuo UEMURA Director Office of Medical Devices III Pharmaceuticals and
More informationCHINA PHARMACEUTICAL NEWSLETTER
Volume VII 2012 CHINA PHARMACEUTICAL NEWSLETTER The Fourth Inter-ministerial Coordination Joint Meeting on Combating the Production and Sales of Counterfeit Drugs convened On June 15, 2012, the Fourth
More informationRegulation of vaccines: building on existing drug regulatory authorities
WHO/V&B/99.10 ORIGINAL: ENGLISH DISTR.: GENERAL Regulation of vaccines: building on existing drug regulatory authorities DEPARTMENT OF VACCINES AND OTHER BIOLOGICALS World Health Organization Geneva 1999
More informationThe European Medicines Agency Inspections ANNEX IV TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA:
The European Medicines Agency Inspections London, 20 September 2007 EMEA/INS/GCP/197221/2005 Procedure no.: INS/GCP/3/IV ANNEX IV TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: SPONSOR
More informationA NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program
A NUSAGE-PharmEng Pharmaceutical and Biotechnology Training Program Shaping Human Capital for Challenges in the Pharmaceutical Industry BIOPHARMACEUTICAL TECHNOLOGY TRANSFER Instructor Loh Kean Chong Date
More informationOctober 25, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852
701 Pennsylvania Avenue, NW Suite 800 Washington, D.C. 20004 2654 Tel: 202 783 8700 Fax: 202 783 8750 www.advamed.org Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers
More informationGuidance Notes on the Application for Certificate for Clinical Trial and Medicinal Test
Guidance Notes on the Application for Certificate for Clinical Trial and Medicinal Test According to section 129 of the Chinese Medicine Ordinance (Cap. 549), for the purpose of facilitating the conduct
More informationComparative Overview of Other Medical Devices Regulatory Systems
Comparative Overview of Other Medical Devices Regulatory Systems Dr David Jefferys, BSc MD, FRCP, FFPM Medical Device Expert Senior Vice President Global Regulatory, Healthcare Policy and Corporate Affairs
More informationUnderstanding the landscape: a strategic approach to registration in China. David Harrison VP QA RA Asia Pacific, Alere Inc.
Understanding the landscape: a strategic approach to registration in China David Harrison VP QA RA Asia Pacific, Alere Inc. cknowledgements to: Alere Inc: Jillianne Coles Samara Zhu Brandwood Biomedical:
More informationIpswich Public Schools
Ipswich Public Schools Executive Search Consultant Services for the position of Superintendent of Schools December 2016 I. RFQ Timeline and Decision to Use a Request for Quotes Time Line Superintendent
More informationGxP Auditing, Remediation, and Staff Augmentation
GxP Auditing, Remediation, and Staff Augmentation TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 5 GLP Auditing 6 Pharmacovigilance Auditing 6 Vendor/Supplier Auditing 7
More informationClinicalTrials.gov REGISTRATION REQUIREMENTS
ClinicalTrials.gov REGISTRATION REQUIREMENTS Background: What is it? ClinicalTrials.gov is a public registry that provides easy access to information on clinical studies, both clinical trials and observational
More information